OMEGA HEALTHCARE INVESTORS INC
For the period ended Mar 31, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 2, 2025
OHI$48.70-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
Unaudited (in thousands)
| | | | | | | |
|---|---|---|---|---|---|---|
| | Three Months Ended March 31, | |||||
| · 2025 · 2024 | ||||||
| Cash flows from operating activities · · | ||||||
| Net income | | $112,060 | | $69,346 | ||
| Adjustment to reconcile net income to net cash provided by operating activities: | | | | |||
| Depreciation and amortization | | 79,875 | | 74,557 | ||
| Impairment on real estate properties | | 1,235 | | 5,292 | ||
| Straight-line rent and other write-offs | | 10,000 | | — | ||
| Provision for credit losses | | 5,092 | | 8,470 | ||
| Amortization of deferred financing costs and loss on debt extinguishment | | 1,380 | | 4,959 | ||
| Stock-based compensation expense | | 15,812 | | 9,227 | ||
| (Gain) loss on assets sold – net | | (10,075) | | 1,391 | ||
| Straight-line rent and effective interest receivables | | (12,583) | | (9,201) | ||
| Interest paid-in-kind | | | (2,471) | | | (3,575) |
| (Income) loss from unconsolidated joint ventures | | | (121) | | | 827 |
| Other non-cash items | | 255 | | (497) | ||
| Change in operating assets and liabilities – net: | | | | |||
| Contractual receivables | | (1,425) | | 915 | ||
| Lease inducements | | (9,750) | | 233 | ||
| Other operating assets and liabilities | | (7,332) | | (10,470) | ||
| Net cash provided by operating activities | | 181,952 | | 151,474 | ||
| Cash flows from investing activities | | | | | ||
| Acquisition deposit | | (30,111) | | — | ||
| Acquisition of real estate | | (58,365) | | (13,262) | ||
| Net proceeds from sale of real estate investments | | 120,881 | | 10,089 | ||
| Investments in construction in progress | | (15,081) | | (14,506) | ||
| Investment in loan receivables and other | | (41,111) | | (48,113) | ||
| Collection of loan principal | | 62,757 | | 14,342 | ||
| Investments in unconsolidated joint ventures | | | (1,014) | | | (61) |
| Distributions from unconsolidated joint ventures in excess of earnings | | 1,156 | | 942 | ||
| Capital improvements to real estate investments | | (20,173) | | (6,941) | ||
| Proceeds from net investment hedges | | — | | 8,429 | ||
| Receipts from insurance proceeds | | 322 | | 1,627 | ||
| Net cash provided by (used in) investing activities | | 19,261 | | (47,454) | ||
| Cash flows from financing activities | | | ||||
| Payments of long-term borrowings | | (400,600) | | (41,878) | ||
| Payments of financing related costs | | — | | (1,283) | ||
| Net proceeds from issuance of common stock | | 260,723 | | 32,350 | ||
| Dividends paid | | (189,218) | | (164,758) | ||
| Distributions to Omega OP Unit Holders | | (18,603) | | (10,452) | ||
| Net cash used in financing activities | | (347,698) | | (186,021) | ||
| Effect of foreign currency translation on cash, cash equivalents and restricted cash | | 1,822 | | 297 | ||
| Decrease in cash, cash equivalents and restricted cash | | (144,663) | | (81,704) | ||
| Cash, cash equivalents and restricted cash at beginning of period | | 548,735 | | 444,730 | ||
| Cash, cash equivalents and restricted cash at end of period | | $404,072 | | $363,026 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.